Other News To Note
Monday, April 25, 2011
Inspire Pharmaceuticals Inc., of Raleigh, N.C., postponed its annual stockholders' meeting indefinitely due to its recently disclosed merger agreement with Monarch Transaction Corp., a subsidiary of Whitehouse Station, N.J.-based Merck & Co. Inc. The deal values Inspire at $5 per share, or about $430 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.